Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
September 14, 2023
COVID-19 is fading from public discussion, countries’ , and hopes for a safer and fairer future are being dashed by potentially watered-down political commitments. Yet people around the world continue to feel the impacts of COVID-19 every day, other infectious disease threats have not magically gone...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
Blog Post
August 22, 2023
A recent, thought-provoking blog by our colleague, Justin Sandefur, titled “How Economists got Africa’s AIDS Epidemic Wrong”, has sparked a debate about the historical role of cost-effectiveness analysis in assessing the investments of the President's Emergency Plan for AIDS Relief (PEPFAR) and, imp...
CGD NOTES
August 18, 2023
The World Health Organization (WHO) declared the end of the Public Health Emergency of International Concern (PHEIC) for COVID-19 on May 5 and for mpox on May 11, 2023. Throughout its use, the meaning of the PHEIC has been muddled. We call for a new, objective epidemic scale that better communicates...
Blog Post
August 16, 2023
Despite verbal nods to global cooperation, equity, and solidarity, the COVID-19 pandemic laid bare a brutal realpolitik: all countries will put their citizens first and vaccinate their own populations, before offering charitable leftovers beyond their own borders. Sub-Saharan Africa, more than any o...
CGD NOTES
August 09, 2023
Assessment of health system performance is a complex task, especially amid major political change, structural reforms, and a global pandemic. The Health Policy paper by Felicia Marie Knaul and colleagues in The Lancet identifies many challenges to improving the performance of the Mexican health syst...
POLICY PAPERS
August 07, 2023
A main driver of antimicrobial resistance is the misuse and overuse of antimicrobials. But lack of access to antimicrobials causes a large mortality burden and contributes to the spread of resistant infections. How can learnings from the use of control policies in other areas of medicine be translat...
Blog Post
August 07, 2023
In a new paper, we argue that the idea of “stewardship”—and the tension between some stewardship policies and patient access—extends well beyond antimicrobials, to all drug classes. We consider the many reasons why governments opt to impose controls on medicines, and how rationales for control relat...
Blog Post
August 03, 2023
As India emerges as a key player in global health, it is important to ask which areas offer the greatest opportunity to advance international cooperation. This essay describes India’s historical influences and highlights current and future directions for India’s role in global health, particularly a...
Blog Post
August 03, 2023
On August 1, 2023, the US Secretary of State Antony Blinken launched the new Bureau of Global Health Security and Diplomacy at the Acheson Auditorium in the State Department. Reorganizing government is unglamorous and rife with political hazards, but it has the potential to build a faster and better...